### Deal Terms Analysis, Life Sciences

[2025 Life Sciences M&A Earnout Achievement: Key Findings by Industry Sector](https://www.srsacquiom.com/our-insights/life-sciences-ma-earnout-achievement-2025/)

### Deal Terms Analysis, Life Sciences

[2025 SRS Acquiom Life Sciences M&A Study](https://www.srsacquiom.com/our-insights/life-sciences-m-and-a-study/)

### Deal Terms Analysis, Life Sciences

[Bio/Pharma M&A: Earnout Achievement Insights](https://www.srsacquiom.com/our-insights/bio-pharma-m-a-trends/)

### Life Sciences

[Life Sciences M&A: Are You Prepared for Post-Closing Challenges?](https://www.srsacquiom.com/our-insights/ma-life-sciences/)

### Life Sciences

[2023 Life Sciences M&A Earnout Achievement: Key Findings by Industry Sector](https://www.srsacquiom.com/our-insights/life-sciences-mergers-and-acquisitions/)

### Deal Terms Analysis, Life Sciences

[2023 SRS Acquiom Life Sciences M&A Study](https://www.srsacquiom.com/our-insights/life-sciences-m-and-a-study-2023/)

### Life Sciences

[Life Sciences M&A: The Midyear Pulse](https://www.srsacquiom.com/our-insights/life-science-mergers-acquisition/)

### Life Sciences

[Life Sciences M&A in 2023: Protecting Your Next Deal](https://www.srsacquiom.com/our-insights/life-sciences-m-and-a/)

### Life Sciences

[Top M&A Milestones: The COVID Impact](https://www.srsacquiom.com/our-insights/ma-milestones/)

### Life Sciences

[Life Sciences M&A in a Pandemic World](https://www.srsacquiom.com/our-insights/life-sciences-ma/)

### Deal Terms Analysis, Life Sciences

[2021 Life Sciences M&A Study](https://www.srsacquiom.com/our-insights/life-sciences-deal-terms/)

### Life Sciences, Shareholder Representation

[How to Structure Earnouts in M&A](https://www.srsacquiom.com/our-insights/earnouts-in-ma/)

### Life Sciences, Shareholder Representation

[A Review of Earnouts in M&A Transactions](https://www.srsacquiom.com/our-insights/earnouts-in-m-a/)